Drug patents

 
Published: Saturday 04 July 2015

Big pharmaceutical companies in the US are rejoicing over a new Food and Drug Administration ruling that gives them an extension of 3 years on their drug patents. Consumer groups are not exactly delighted at the change because it could cost consumers billions of dollars, since companies that make cheaper "generic" alternatives to brand-name drugs on which the patents have expired would be left out in the cold. These companies have called on the Congress to amend the law.

Subscribe to Weekly Newsletter :

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.